Beginning August 7, 2020, Rainbow Health Ontario (RHO), a program of Sherbourne Health, will be offering our new CME-approved training for Ontario primary healthcare providers, Puberty Suppression for Trans Youth in Primary Health Care. This scheduled course with live facilitation is now available on select dates through December 2020 by registering for our recently launched online learning platform, LGBT2SQ Health Connect, and self-enrolling. More dates will become available soon. 

Enrollment for this course is open to prescribers as well as Registered Nurses and Physician Assistants who work closely with them. By the end of the training session, participants will be able to:

  • assess gender dysphoria in adolescents;
  • assess capacity to consent to treatment;
  • identify puberty blockers’ criteria and contraindications;
  • conduct medical investigations prior to treatment and monitoring during treatment; and
  • provide treatment to youth in a collaborative way.

The content for this course was developed by CHEO’s Dr. Karine Katchadourian, a Paediatric Endocrinologist, and Cathy Maser, a Nurse Practitioner and Paediatric Team Lead at Sick Kids’ Transgender Youth Clinic. RHO collaborated on producing the course, with additional support from Dr. Amy Bourns, a Sherbourne Health Family Physician and the author of the 4th edition of Sherbourne’s Guidelines for Gender-Affirming Primary Care with Trans and Non-Binary Patients

Puberty Suppression for Trans Youth in Primary Health Care has been accredited by the College of Family Physicians of Canada and the Ontario Chapter for up to 5.0 Mainpro-M1 credits. Other modules on LGBT2SQ Health Connect are also eligible for MainPro credits, such as the LGBT2SQ Health Foundations course currently available on demand.

All training on LGBT2SQ Health Connect is free for healthcare providers in Ontario until Dec. 31, 2020, after which time a cost recovery-based pricing model will be phased in. 


Colleen Westendorf
Pronouns: She/Her